Clozapine Tablets USP — Class II drug recall D-0705-2017
Terminated recall by Teva Pharmaceuticals USA, reported 2017-05-17, distributed nationwide. Microbial Contamination of Non-Sterile Products
| Recall number | D-0705-2017 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Teva Pharmaceuticals USA, North Wales, PA, United States |
| Recall initiated | 2017-04-24 |
| Classified | 2017-05-11 |
| Reported by FDA | 2017-05-17 |
| Terminated | 2018-02-02 |
| Distributed | Nationwide (US) |
| Reason classes | microbial contamination, sterility |
| NDC | 00093-4359-01, 00093-4359-05, 00093-4359-19, 00093-4359-93 |
| Lot numbers | 03/18, 07C160, 07C160A, 100 |
Product
Clozapine Tablets USP, 25 mg, 100-count bottle (NDC 0093-4359-01), 500- count bottle (NDC 0093-4359-05), 100 Unit Dose Blisters per carton (NDC 0093-4359-93), Individual Blister Pack (NDC 0093-4359-19), Rx Only, Manufactured By: Teva Pharmaceutical Industries Ltd., Jerusalem, 9777600, Israel
Reason for recall
Microbial Contamination of Non-Sterile Products
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0705-2017. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.